Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
12 2022
Historique:
revised: 26 05 2022
received: 11 05 2021
accepted: 23 06 2022
pubmed: 19 7 2022
medline: 17 12 2022
entrez: 18 7 2022
Statut: ppublish

Résumé

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of death in patients with SSc with unclear pathogenesis and limited treatment options. Evidence strongly supports an important role for profibrotic secreted phosphoprotein 1 (SPP1)-expressing macrophages in SSc-ILD. This study was undertaken to define the transcriptome and chromatin structural changes of SPP1 SSc-ILD macrophages in order to better understand their role in promoting fibrosis and to identify transcription factors associated with open chromatin driving their altered phenotype. We performed single-cell RNA sequencing (scRNA-Seq) on 11 explanted SSc-ILD and healthy control lung samples, as well as single-cell assay for transposase-accessible chromatin sequencing on 5 lung samples to define altered chromatin accessibility of SPP1 macrophages. We predicted transcription factors regulating SPP1 macrophages using single-cell regulatory network inference and clustering (SCENIC) and determined transcription factor binding sites associated with global alterations in SPP1 chromatin accessibility using Signac/Seurat. We identified distinct macrophage subpopulations using scRNA-Seq analysis in healthy and SSc-ILD lungs and assessed gene expression changes during the change of healthy control macrophages into SPP1 macrophages. Analysis of open chromatin validated SCENIC predictions, indicating that microphthalmia-associated transcription factor, transcription factor EB, activating transcription factor 6, sterol regulatory element binding transcription factor 1, basic helix-loop-helix family member E40, Kruppel-like factor 6, ETS variant transcription factor 5, and/or members of the activator protein 1 family of transcription factors regulate SPP1 macrophage differentiation. Our findings shed light on the underlying changes in chromatin structure and transcription factor regulation of profibrotic SPP1 macrophages in SSc-ILD. Similar alterations in SPP1 macrophages may underpin fibrosis in other organs involved in SSc and point to novel targets for the treatment of SSc-ILD, specifically targeting profibrotic macrophages.

Identifiants

pubmed: 35849803
doi: 10.1002/art.42286
pmc: PMC9771864
mid: NIHMS1819536
doi:

Substances chimiques

Transcription Factors 0
Chromatin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2003-2014

Subventions

Organisme : NIAMS NIH HHS
ID : P50 AR060780
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL123766
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI089443
Pays : United States

Informations de copyright

© 2022 American College of Rheumatology.

Références

Lancet. 2016 Jun 25;387(10038):2630-2640
pubmed: 27156934
Am J Respir Cell Mol Biol. 2003 Dec;29(6):743-9
pubmed: 12805086
Nat Immunol. 2013 Oct;14(10):986-95
pubmed: 24048120
Respir Med. 2007 Oct;101(10):2199-206
pubmed: 17643278
Cells. 2020 Jan 04;9(1):
pubmed: 31947943
Arthritis Res Ther. 2005;7(1):R71-9
pubmed: 15642145
Trends Immunol. 2005 Nov;26(11):587-95
pubmed: 16168711
Genes Immun. 2009 Apr;10(3):210-8
pubmed: 19129850
Arthritis Rheum. 2011 Mar;63(3):783-94
pubmed: 21360508
Cell Rep Med. 2020 Nov 17;1(8):100140
pubmed: 33294861
Circulation. 2006 May 30;113(21):2548-55
pubmed: 16735689
Nat Methods. 2021 Nov;18(11):1333-1341
pubmed: 34725479
Eur Respir J. 2019 Aug 22;54(2):
pubmed: 31221805
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337479
Front Microbiol. 2018 Jan 15;8:2686
pubmed: 29379481
N Engl J Med. 2018 Jan 4;378(1):35-47
pubmed: 29298160
Cell Immunol. 2018 Aug;330:27-42
pubmed: 29429624
Nat Rev Rheumatol. 2014 Dec;10(12):706-19
pubmed: 25136781
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Front Immunol. 2020 Jan 10;10:2993
pubmed: 31998297
EMBO J. 2019 Oct 1;38(19):e101233
pubmed: 31414712
Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81
pubmed: 21680953
Ann Rheum Dis. 2018 Feb;77(2):212-220
pubmed: 29066464
Eur Respir J. 2011 Dec;38(6):1461-7
pubmed: 21700608
Nat Methods. 2017 Nov;14(11):1083-1086
pubmed: 28991892
Genome Res. 2019 Aug;29(8):1363-1375
pubmed: 31340985
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Matrix Biol. 2018 Aug;68-69:355-365
pubmed: 29567124
Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
pubmed: 16415274
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Cell Signal. 2019 Dec;64:109408
pubmed: 31473307
Ann Rheum Dis. 2018 Sep;77(9):1362-1371
pubmed: 29853453
N Engl J Med. 2019 Jun 27;380(26):2518-2528
pubmed: 31112379
Ann Rheum Dis. 2019 Oct;78(10):1379-1387
pubmed: 31405848
J Clin Invest. 2019 May 28;129(8):3293-3309
pubmed: 31135379
J Leukoc Biol. 2005 Jul;78(1):14-26
pubmed: 15784687
Leukemia. 2018 Feb;32(2):438-449
pubmed: 28745329
Arthritis Rheum. 2007 May;56(5):1685-93
pubmed: 17469163
J Invest Dermatol. 2012 Jun;132(6):1605-14
pubmed: 22402440
Am J Respir Cell Mol Biol. 2015 Feb;52(2):217-31
pubmed: 25029475
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626759
Arthritis Care Res (Hoboken). 2012 Apr;64(4):519-24
pubmed: 22213733
Nat Commun. 2019 Apr 12;10(1):1693
pubmed: 30979895
Am J Nephrol. 2010;32(3):262-71
pubmed: 20714131
Nat Genet. 2009 May;41(5):553-62
pubmed: 19377474
Proc Natl Acad Sci U S A. 2017 May 2;114(18):4757-4762
pubmed: 28424250
Ann Rheum Dis. 2007 Jul;66(7):940-4
pubmed: 17329309
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
PLoS Med. 2005 Sep;2(9):e251
pubmed: 16128620
Nucleic Acids Res. 2012 Aug;40(15):e114
pubmed: 22718975
Arthritis Rheumatol. 2014 Mar;66(3):714-25
pubmed: 24574232
Nat Rev Genet. 2014 Feb;15(2):69-81
pubmed: 24342920
Lancet Respir Med. 2020 Oct;8(10):963-974
pubmed: 32866440

Auteurs

Anna Papazoglou (A)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Mengqi Huang (M)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Melissa Bulik (M)

Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.

Annika Lafyatis (A)

Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.

Tracy Tabib (T)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Christina Morse (C)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.

John Sembrat (J)

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Mauricio Rojas (M)

Division of Pulmonary, Critical Care and Sleep Medicine, Ohio State University, Columbus.

Eleanor Valenzi (E)

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Robert Lafyatis (R)

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH